CJC-1295 (DAC) – 5mg
$40.00
CJC-1295 (DAC)
CJC-1295 (DAC) is a synthetic peptide that has been studied for its potential to stimulate growth hormone release by enhancing the function of the pituitary gland. The DAC (Drug Affinity Complex) modification increases its half-life, allowing for prolonged action and more sustained release of growth hormone. This peptide is of interest in research for its potential effects on muscle growth, fat metabolism, and overall tissue repair.
Potential Research Applications
CJC-1295 (DAC) is currently being explored in research settings for its role in:
- Growth Hormone Stimulation: Investigated for its potential to enhance the release of growth hormone, supporting muscle growth and tissue repair.
- Muscle & Fat Metabolism: Studied for its effects on muscle mass development and fat reduction.
- Anti-Aging & Regeneration: Researched for its potential to support regeneration and overall metabolic health through growth hormone modulation.
✔ High-Quality Research Peptide – Produced under stringent quality control standards.
✔ Lab-Tested for Purity – Ensures consistency for scientific studies.
✔ Research Use Only – Not for human consumption or medical applications.
✔ Peptides – Will arrive in a lyophilized (powder) form for maximum stability.
The peptides are available for research and laboratory purposes only. Please review and ahere to our Terms and Conditions before ordering.
- Description
- Certificate of Analysis
CJC-1295 (DAC) is a synthetic peptide studied for its ability to modulate growth hormone (GH) release. As a modified analog of growth hormone-releasing hormone (GHRH), CJC-1295 incorporates drug affinity complex (DAC) technology, which extends its half-life and enhances its biological activity. This modification enables prolonged effects on GH secretion compared to traditional GHRH.
Research focuses on CJC-1295’s ability to stimulate the pituitary gland, increasing GH and insulin-like growth factor 1 (IGF-1) levels. The peptide promotes a natural, pulsatile release of GH, mimicking the body’s physiological rhythm and avoiding the fluctuations caused by direct GH administration. This sustained GH release may affect cellular metabolism, protein synthesis, and tissue regeneration.
Studies suggest that CJC-1295 supports muscle protein synthesis, metabolic regulation, and tissue maintenance. Additionally, preclinical research explores its potential to influence lipolysis, breaking down stored fat, and impact lean tissue composition. The extended duration of action, due to the DAC modification, differentiates CJC-1295 from shorter-acting GHRH analogs, making it an interesting subject in endocrine modulation research.
Research also investigates CJC-1295 for its potential in cellular recovery and tissue integrity. By enhancing GH release, CJC-1295 may support regenerative processes, benefiting various physiological functions. Studies further explore its impact on sleep patterns, immune function, and metabolic efficiency.
The pharmacokinetic profile of CJC-1295, with its extended half-life and sustained activity, has gained attention in scientific research. This characteristic allows for less frequent administration while maintaining stable GH levels. Despite these promising findings, researchers continue to investigate CJC-1295’s long-term effects and potential applications in biomedical studies.
For Research Use Only
No Certificate of Analysis images available for this product.
